DI BARI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 675
EU - Europa 222
AS - Asia 69
AF - Africa 7
SA - Sud America 2
Totale 975
Nazione #
US - Stati Uniti d'America 673
IT - Italia 125
IN - India 32
SE - Svezia 32
FI - Finlandia 25
CN - Cina 22
SG - Singapore 15
BG - Bulgaria 8
DE - Germania 6
GB - Regno Unito 6
TG - Togo 5
RO - Romania 4
UA - Ucraina 4
FR - Francia 3
IE - Irlanda 3
BE - Belgio 2
CA - Canada 2
NL - Olanda 2
AR - Argentina 1
BR - Brasile 1
CH - Svizzera 1
CI - Costa d'Avorio 1
ES - Italia 1
ZA - Sudafrica 1
Totale 975
Città #
Fairfield 148
Ashburn 74
Rome 59
Woodbridge 58
Houston 54
Seattle 44
Cambridge 39
Wilmington 31
Fasano 30
Chandler 26
Tappahannock 19
Princeton 18
Beijing 17
San Paolo di Civitate 16
Plano 15
Helsinki 13
Lawrence 12
Singapore 11
Ann Arbor 9
Boston 8
Sofia 8
Millbury 7
San Diego 7
Cagliari 6
Andover 5
Dearborn 5
Lomé 5
New York 4
Dublin 3
Norwalk 3
Phoenix 3
Bari 2
Brussels 2
Bühl 2
Cluj-napoca 2
Palermo 2
Pune 2
Toronto 2
Vado Ligure 2
Abidjan 1
Amsterdam 1
Berlin 1
Bern 1
Bremen 1
Chaoyang 1
Chengdu 1
Chieti 1
Derio 1
Des Moines 1
Falls Church 1
Federal 1
Fremont 1
Grafing 1
Jacksonville 1
Jinan 1
Kunming 1
London 1
Los Angeles 1
Muizenberg 1
Nanjing 1
Prescot 1
Provo 1
Redmond 1
San Mateo 1
Stockholm 1
São Paulo 1
Washington 1
Totale 801
Nome #
Nicotinic receptor activation negatively modulates pro-inflammatory cytokine production in multiple sclerosis patients 97
The activation of M2 muscarinic receptor inhibits cell growth and survival in human glioblastoma cancer stem cells 86
Mir-34a-5p Mediates Cross-Talk between M2 Muscarinic Receptors and Notch-1/EGFR Pathways in U87MG Glioblastoma Cells: Implication in Cell Proliferation 86
Dysregulated homeostasis of acetylcholine levels in immune cells of RR-multiple sclerosis patients 83
The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype 80
M2 muscarinic receptors inhibit cell proliferation in human glioblastoma cell lines 79
Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: Implication in peripheral inflammation 78
Cholinergic system and neuroinflammation: implication in multiple sclerosis 69
M2 receptor activation inhibits cell cycle progression and survival in human glioblastoma cells 68
Cytotoxic and genotoxic effects mediated by M2 muscarinic receptor activation in human glioblastoma cells 64
M2 MUSCARINIC RECEPTORS INHIBIT CELL PROLIFERATION AND MIGRATION IN UROTHELIAL BLADDER CANCER CELLS 56
Comparative study of the expression of cholinergic system components in the CNS of experimental autoimmune encephalomyelitis mice: Acute vs remitting phase 55
Cytostatic and cytotoxic effects induced by M2 muscarinic receptor activation on human glioblastoma cells 32
null 32
Role of muscarinic receptors in tumors: possible therapeutic implications 29
CYTOSTATIC AND CYTOTOXIC EFFECTS INDUCED BY M2 MUSCARINIC RECEPTOR ACTIVATION ON HUMAN GLIOBLASTOMA CELL LINES 25
Inflammatory cytokines and cholinergic system dis-function in multiple sclerosis patients. 6
Totale 1.025
Categoria #
all - tutte 2.812
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.812


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020242 35 13 5 9 27 26 31 26 25 22 15 8
2020/2021119 7 9 39 3 1 3 2 14 8 19 9 5
2021/2022171 0 7 35 4 18 2 16 22 9 11 20 27
2022/2023143 32 43 9 12 9 8 3 6 9 0 7 5
2023/2024112 8 11 8 14 10 17 3 24 2 7 2 6
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 1.025